infections ISU Flashcards

1
Q

3 things that are necessary for infection to occur

A

source - where the micro-organism lives
susceptible person - with a way for micro-organism to enter the body
transmission - a way for the micro-organism to move to the susceptible person.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

name 3 types of transmission, what PPE is used to protect us, and example infections

A

contact. handwashing, gloves and aprons, MRSA, C.difficile

Droplet, eye protection,surgical masks, influenza + COVID-19

Aerosol, Eye protection, masks, MDR-TB, COVID-19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 moments of hand hygiene

A

1- before touching patient
2-before aseptic procedure
3-after body fluid exposure risk
4-after touching patient
5-after touching patient surroundings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the problems of antimicrobial resistance?

A
  • delay in appropriate antibiotic therapy
    -increased hospital length stay
    -alternative antibiotics need to be used that aren’t first line (may cause adverse effects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the causes of antimicrobial resistance?

A
  • over prescribing of antibiotics
  • patient non-compliance
  • poor quality of antibiotics
    -antibiotics use in domestic animals
  • poor hygiene + sanitisation
    -lack of new antibiotics being developed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the importance of rapid diagnosis and antimicrobial susceptibility testing?

A
  • organism identification can lead to more appropriate antibiotics treatment.
  • improves the patient outcome
    -use of narrow spectrum antibiotic earlier and IV to oral step down earlier.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what factors influence the behaviours of prescribers in antimicrobial use?

A
  • lack of awareness of guidelines
    -time constraints
    -decision fatigue
  • uncertain diagnosis
  • pressure from patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the epidemiology of infectious disease

A

the study of how often diseases occur in different groups of people and why

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name different modes of pathogen transmission, role of patient host defence mechanisms to recommend and rationalise interventions that prevent infectious disease.

A

1-transmission between humans e.g. contact
2-environmental e.g. water
3- vectors e.g. animals
Host prevention:
- barrier immunity e.g. skin
-innate immunity e.g. inflammatory response.
-adaptive immunity e.g. specific antibody production.

interventions that prevent infectious disease:

  • prophylaxis e.g. for malaria
  • sanitisation of drinking water
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the spectrum of activity of antibiotics + microorganisms of interest

A

a system that shows how susceptible a microorganism is to the treatment of a specific antibiotic. For example the gram-negative bacteria E.coli is susceptible to amoxicillin/ clavulanate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

discuss general steps involved in infection pathogenesis

A

colonisation - establish residence at site of infection
invasion - breach host barriers and gain access to deeper tissue
proliferation - multiply and spread within the host
dissemination - spread to other sites or other host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the mechanism by which pathogens adhere to host cells, evade immune system and cause tissue damage

A

1 - adherence through Pili, adhesins or biofilms to allow bacteria to stick to surfaces of host cells.

2- immune evasion by antigenic variation, intracellular survival and inhibition of phagocytosis.

3- tissue damage by releasing toxins, inflammation and host cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the systemic effects of infection such as fever, sepsis, organ failure

A

1- fever elevated body temp above 38 in response to infection.
2-sepsis response to infection characterised by widespread inflammation and organ dysfunction
3-organ failure due to vasodilation of both arteries and veins when experiencing septic shock.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the origins of clinical markers for infections e.g. fever, C-reactive protein, immunoglobulins

A

markers for a fever include temp greater than 38 or less than 36, HR greater than 90bpm, tachypnoea greater than 20bpm, WBC count greater than 12000/mm^3.

C-reactive protein is produced by the liver in response to inflammation.

immunoglobulins are different antibodies which can be detected in the blood plasma when the body is fighting infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the importance of understanding pathophysiology of infection in diagnosing and management of complications?

A

We can ensure we don’t get a differential diagnosis and we are more accurate, allowing us to select the appropriate treatment to the right patient within the right timeframe. This ensures that we don’t get to the late stages of infection where organ failure or sepsis shock occur - leading to death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

summarise the innate immune system

A
  • non - specific
    -defence against entry of microorganisms via physical barriers and secretions
    -when penetrated mediated by phagocytic cells e.g. macrophages, neutrophils, and NK cells. creates inflammatory response via release of histamines. NK cells kill recognisable cells using chemicals that damage cell membranes.
  • Also has an alternate pathway gets activated after opsonization of pathogen (complement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

summarise the adaptive immune system

A
  • specific and memory
  • antigen on APC is recognised by lymphocytes via B cell and T cell receptors.
  • proliferation of lymphocytes that recognise the antigen.
    -by MHC molecule/ MHC complex.
    -production of specific antibodies.
  • first exposure is B-cells that produce antibodies.
    -secondary response T-memory cells form plasma cells more quickly.
    -key cells are T helper cells that release cytokines and cytotoxic T cells that target virus infected cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does the immune system respond to viral infection

A

1- extracellular phase: either acts as opsonin’s for macrophages or is bound to pre existing antibodies to prevent entry to target cells.
2- if not effective macrophages present antigen fragments on surface + secrete cytokines which stimulates NK and Thelper cells but also makes interferons.
3- helper t cells bind to antigen on macrophage which activates them causing release of cytokines to stimulate B lymphocytes (plasma cells to make antibodies) and cytotoxic T lymphocytes.
4 - production of more antibodies via plasma cells after B lymphocyte activation.
5-cytotoxic T cells recognise MHC I complex and cause infected host cell to undergo apoptosis.

In some cases infected host cells withdraw MHC complex from surface which is recognised by NK cells - leading to apoptosis of infected cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how does the immune system respond to bacterial infection

A
  • extracellular response - inflammation
  • complement is activated acting as opsonins to activate phagocytosis.
    -degranulation of mast cells release histamine and chemo attractants.
    -complement cascade ends with formation of membrane attack complex.
    Other innate response:
    -phagocytes are activated and macrophages begin to ingest.
    -antibodies + complement/opsonins coat to help with identification.
  • enhances phagocytosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the functions of specific immune cells in the innate immune response

A

neutrophils - first to site + increase inflammation response + recruit other cells to site
macrophages - clean up dead neutrophils and responsible for phagocytosis.
Basophils,mast cells,eosinophils - when activated release histamine and leukotrienes to help inflammatory response.
NK cells - recognise infected viral cells and cause apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

describe the role of infection agents and the immune system in pneumonia

A

Can be caused by both bacteria and viruses

  • changes in airway direction trap pathogens.
    -epiglottis and cough reflex protect lower airways
    -ciliated epithelium propels mucous upwards towards the mouth
  • at site of alveoli T-cell mediated immunity, humoral immunity and inflammatory responses occur to defend lower respiratory tract infections.
    -macrophages and neutrophils inactivate the bacteria and compliment and antibodies produced help with opsonisation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is CAP diagnosed and classified in terms of severity

A
  • patient history
    -increase in CRP + WCC through blood tests
    -patient observations e.g. BP, temp, HR, resp rate, and O2 saturation.
    -chest x-ray

Usually caused by step or influenza viruses

severity based on CRB-65(primary) or CURB-65(hospital) score. One point for each of the following: confusion, Urea>7mmol/L, resp rate >30/min,BP less than 90 systolic and less than 60 diastolic, and over the age of 65.

CRB-65 severity :
0 = low
1-2 = intermediate
3-4 = high

CURB-65 severity :
0-1 = low
2 = intermediate
> 3 = high.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How is HAP diagnosed and classified in term of severity

A

diagnosed through chest x-ray + either fever or WCC plus any of the following:
- increased resp/ secretions , SOB, cough, new confusion.

not deemed severe unless symptoms such as: new confusion, resp rate >30/min, bilateral on chest x-ray, sepsis , multi organ dysfunction , new resp failure, require critical care.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how are acute ineffective exacerbations of COPD diagnosed and classified in terms of severity

A

-history of COPD, worsening of symptoms and trigger identification. Symptoms inculde: SOB, increased cough, changes in sputum production, icreased fatigue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

summarise antibiotic treatment for CAP

A

Low severity treatment (duration 5 days):
non-pen allergy = amoxicillin (PO) 500mg TDS
pen allergy = Doxycycline (PO) 200mg STAT, 100mg OD or Clarithromycin (PO) 500mg BD.

moderate ( duration 5 days):
non-pen allergy = amoxicillin (PO) 500mg-1000mg TDS + Clarithromycin (PO) 500mg BD.
Doxycycline (PO) 200mg STAT, 100mg OD
or Clarithromycin (PO) 500mg BD

High severity:
non-pen allergy = co-amoxiclav (PO/IV), PO 625mg TDS, IV 1.2g TDS + clarithromycin 500mg BD (PO)

pen allergy = Levofloxacin (PO/IV) 500mg BD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

summarise antibiotic treatment for HAP

A

non - severe (5 days):
non-pen allergy: Co-amoxiclav (PO) 625mg TDS.
Pen allergy: Doxycycline (PO) 200mg STAT, 100mg OD
or Co-trimoxazole (PO) 960mg BD
or Levofloxacin (PO) 500mg OD-BD

Severe (5 days):
non-pen allergy: Tazocin (IV) 4.5g TDS
non severe pen allergy: Meropenem (IV) 1g TDS
severe pen allergy: Levofloxacin (IV) 500mg OD-BD

27
Q

summarise antibiotic treatment for IECOPD

A

non-severe (5 days):
- non - pen allergic: Amoxicillin (PO) 500mg TDS
- pen allergic:Doxycycline (PO) 200mg STAT, 100mg OD
- or clarithromycin (PO) 500mg BD

IV antibiotic choices:
-amoxicillin 500mg-1g TDS
-co-amoxiclav 1.2g TDS
-clarithromycin 500mg BD
-co-trimoxazole 960mg BD
-Tazocin 4.5g TDS

All patients should also recieve a 5 day course of oral prednisolone 30mg OD

28
Q

difference in therapeutic approach of narrow v broad - spectrum antibiotics.

A

-broad is used to target many types of bacteria caused by an unidentified microorganism or infection from multiple bacteria.
-narrow is effective against a limmited number of bacteria and used when the microorganism has been identified to minimise the disruption of natural flora.

29
Q

how to determine level of antibacterial drug activity + measure effectiveness

A

2 ways:

1) Minimal inhibitory conc (MIC) lowest conc of drug that prevents visible growth of the pathogen (indicates bacterial drug resistance).
2) Minimum bacterialcidal conc (MBC) - lowest conc of drug that kills pathogen.

Bacteriostatic = MBC/MIC ratio > 4

Bacteriocidal = MBC/MIC < 4

30
Q

contrast bacterialcidal and bacterialstatic effects and their properties from the dilution susceptibility tests.

A
  • Broth of agar showing lowest conc with no more growth of pathogen will be MIC.
  • Broth of agar with lowest conc that doesn’t support any of the microbes growth will be MBC.
  • Both conc can now be used to calculate the MBC/MIC ratio to see if the drug is bacterialcidal or bacteriostatic.
31
Q

1) idetntify subclasses of penicillins
2) explain their MoA
3) main adverse effects

A

1)
i) Natural penicillins e.g. Penicillin G and V (narrow spectrum)
ii) Antistaphyloccal penicillins e.g. Flucloxacillin.
iii) Aminopenicillins e.g. Ampicillin or Amoxicillin (broad-spectrum)
iv) Antipseudomonal penicillins e.g. piperacillin or ticarcillin (extended broad - spectrum)

2) Inhibitors of cell wall synthesis:
Block the formation of peptide bridges in peptidoglycan chains and have bacterialcidal effect by binding and blocking transpeptidases (PBP) . Resistant bacterial can produce b-lactamase to inactivate the beta lactam ring. To overcome this beta-lactamase inhibitors can be combined with the drug such as clavulanic acid with amoxicillin to make co-amoxiclav.

3)
Question penicillin allergy before treatment:
Mild = rash, breathing or swallowing difficulties
Severe = anaphylaxis and death
Penicillins have cross-reactivity with all beta - lactams
GI distress
CNS toxicity

32
Q

name the beta-lactam subgroups

A

penicillins e.g. amoxicillin
cephalosporins e.g. cefotaxime
carbapenems e.g. Imipenem
monobactams e.g. Aztreonam

33
Q

Difference between B-lactams and glycopeptides e.g. Vancomycin

A

B-lactams bind to transpeptidases for the inhibition of the cell wall. Whereas glycopeptides such as vancomycin bind to the amino acids linked to NAM in the peptidoglycan to stop cell wall synthesis.

B-lactams can cover both gram + / -ve. Whereas glycopeptides only cover gram +ve.

34
Q

which antibiotics target 30s ribosomes to cause inhibition of protein synthesis?

A

Aminoglycosides e.g. gentamycin (disrupt protein elongation in translation/mRNA misreading) - used for aerobic gram -ve. Bactericidal effect.

Tetracyclines e.g. Doxycycline (Block access of tRNA to ribosome site A). Broad spectrum and has bacteriostatic effect.

35
Q

which antibiotics target the 50s subunit of ribosomes to inhibit protein synthesis?

A

Macrolides e.g. Erythromycin. Prevent translocation step and have bacteriostatic effect. Mostly broad spec.

Lincosamides e.g. clindamycin. Prevent translocation step + bacteriostatic.

Oxazolidinones e.g. Linezolid. Interfere with translation initiation assembly. Bacteriostatic and used against gram +ve

Chloramphenicol - block attachment of tRNA to ribosome site A causing bacteriostatic effect. Broad spectrum.

36
Q

which antibiotics target metabolic pathways acting as antimetabolites?

A

Sulfonamides - compete with PABA as a substrate for the enzyme dihydropteroate synthase so folic acid cannot be produced to produce purines in DNA. Has bacteriostatic effect.

Trimethoprim - competes with Dihydrofolate reductase (DHFR) to stop production of folic acid and DNA. Bacteriostatic effect.

37
Q

how do sulphonamides mimic the structure of PABA to inhibit the enzyme dihydropteroate synthetase?

A

1 - free para amino group for H-bond.
2-para-substituted phenyl ring for VDW’s interactions.
3-sulphanomide for ionic bond
4- both sulphonamide and amino group must be attached directly to aromatic ring.
5- R2 group is the only site that can be varied which will affect PK.

38
Q

how does trimethoprim mimic the general structure of dihydrofolic acid to compete for the binding sites of dihydrofolate reductase?

A
39
Q

SAR of penicillins

A

1- beta - lactam ring is essential
2- COO- essential to bind to NH3+ of Lys on transpeptidase.
3-bicyclic system is important
4-acylamino side chains are essential.
5-sulphur is usual
6- cis stereochemistry of bicyclic ring is important.

40
Q

name some issues with penicillins and how they can be overcome

A

1 - acid - resistant penicillins - influence of acyl side chain can open up lactam ring. Solution introduce EWG to acyl side chain

2- broad spectrum penicillins - limited breadth of activity. Inability to reach outer surface of cell membrane due to hydrophobic barrier in gram -ve bacteria. Solution addition of hydrophilic group attached to carbon at side chain

3- some bacteria express beta lactamases which open up the lactam ring making the antibiotic not effective. Solution adding a bulking group to act as a steric shield or the use of beta lactamase inhibitors

41
Q

difference in structure of cephalosporins v penicillins?

A
  • variations of 7-acylamino side chain
  • variation of 3 - acetoxymethyl side chain
    -extra substitution at C7
42
Q

what antibacterial agents inhibit nucleic acid transcription/replication?

A

Fluroquinolones (end in floxacin) for DNA
Rifamycincs for RNA e.g. Rifampin

43
Q

what antibiotics generate free radicals?

A

nitroimidazoles and nitrofurantoin - both contain nitro group. Reduction of nitro group causes toxic metabolites to be released which damage bacterial DNA

44
Q

how do fluoroquinolones cause inhibition of DNA synthesis?

A
  • Targets Topoisomerases
  • DNA gyrase in gram -ve and topoisomerase IV (human) target gram +ve
  • fluoroquinolones inhibit DNA gyrase and topoisomerase IV making DNA inaccessible –> blocking bacterial DNA replication –> cell death.
45
Q

how do Rifamycins/Rifampicin inhibit RNA synthesis

A
  • inhibit the initiation step of DNA transcription
  • blocks activity of RNA polymerase.
46
Q

Identify the therapeutic agents for tuberculosis

A

Initial treatment (2months):
R - Rifampicin
I - isoniazid
P - pyrazinamide
E - ethambutol
continuation phase (4months):
R - Rifampicin
I - Isoniazid

Retreatment:
Initial = RIPE + streptomycin (2 months)
Continuation = RI + Ethambutol (5months)

47
Q

differences between intrinsic and acquired antibiotic resistance.

A

intrinsic - common with bacterial species. Where bacteria are resistant naturally to an antibiotic usually due to lack of drug target or cell wall being impermeable to the drug.

acquired - not uniform within a species. When there is a change or gene gain caused by mutations, vertical transfer, or horizontal transfer.

48
Q

differences between vertical and horizontal transfer of drug resistance

A

Vertical:
-DNA from parent to offspring (chromosome and plasmids)
-asexual reproduction

Horizontal:
- genetic material transmission to unrelated bacteria.
- plasmid is copied and transferred to recipient cell.

49
Q

describe the mechanism of transformation, transduction, conjugation within the horizontal transfer of drug resistance.

A

1- transformation: bacterial cell taking up DNA from environment from dead donor cells that released DNA.

2 - transduction: transfer of DNA via bacteriophages, no direct contact between bacteria.

3- conjugation: transfer of DNA via sex pili/cell to cell contact from a conjugation tube.

50
Q

explain different antibiotic resistance mechanisms in bacteria.

A

1 - alteration of drug target site such as mutations in enzymes.

2- drug inactivation from bacteria producing enzymes that break down antibiotics e.g. beta lactamases. Or transfer of unusual chemical groups to the antibiotic - making the drug ineffective.

3- Limit drug uptake either due to differences in hydrophobicity of the outer membrane. Or mutations in genes that alter the bacteria’s porins.

4- Drug efflux actively transporting toxic substances out of the plasma membrane.

51
Q

compare virus- and host-targeting antiviral approaches. Pros vs cons?

A

Virus target:

e.g. Sofosbuvir (HCV)-nucleotide inhibitor. Inhibition of viral polymerase.
Adv = selective toxicity to the virus so reduced toxicity to host cells.
Disadv = risk of drug resistance.

Cell-host target:

e.g. Maraviroc (HIV) - targets human CCR5 protein (blocks viral entry)
adv = reduced risk of drug resistance + broad - spec effects.
disadv = reduced specificity (Higher risk S/E)

52
Q

outline main MOA and targets of different classes of antiviral drugs related to the life cycle of a virus.

A

Virus attachment inhibitors (HIV) - prevent proteins in the virus binding to receptors on the surface of the cell.

Viral penetration/fusion inhibitors (HIV) - Enfuvirtide mimics HIV-1 fusion machinery, binding to gp41 and preventing HIV envelope fusion with the cell membrane.

Viral uncoating inhibitors (Influenza) - blocking of M2 proton channel stops the virus from uncoating. M2 blockers are Amantadine and Rimantadine.

Viral polymerase inhibitors (nucleotide inhibitors and non-nucleoside inhibitors) - stops viral replication.

Viral protease inhibitors - stop protein synthesis by binding to viral proteases stronger than the natural substrate + can block active sites.

Viral release inhibition (influenza) - neuraminidase inhibitors are analogues of sialic acid and compete for binding site preventing release of viral progenies.

53
Q

difference between nucleoside/nucleotide and non-nucleoside antiviral agents?

A

nucleoside/nucleotide mimic and compete with natural nucleotides to bind to enzyme active site. Whereas non -nucleotides do not resemble natural nucleotides and bind to the allosteric site.

  • n/n are incorporated into the growing nucleic acid chain. Non - N is not incorporated into nucleic acid chain.
  • n/n terminate polymerase elongation and are needed to be activated by viral kinases to the triphosphate form. Whereas non - n causes enzyme structure rearrangements that inhibit function also they don’t require activation steps.
54
Q

what are the principles of microbial identification?

A

rapidly + accurately identify pathogens responsible for infection.

excludes incorrect diagnosis, best possible therapeutic option is given, antimicrobial susceptibility testing

55
Q

contrast different types of microbial tests to identify microorganisms

A

Rapid tests + immunoassays - Identifies antigen-antibody binding usually identified by rate of colour formation due to enzymes

Microscopy - staining plus use of electron microscope

Culture - use of different media and growth requirements to grow desired organisms.

Biochemical tests - uses growth requirements and enzymatic activities using biochemical kits.

Molecular testing - PCR, allows the growth of desired DNA/RNA with high purity and yield.

56
Q

explain biology of PCR

A

1 - Denaturation: two strands of DNA are separated by heating breaking H bonds.
2- Annealing - rapid process where primers bind to specific target sequence when cooling.
3- Extension - reaction heated to optimum temp for DNA polymerase so efficient DNA synthesis.

57
Q

why is PCR relevant in microbial diagnosis?

A

Primers and PCR are designed to amplify a portion of the microorganisms specific genome. Nucleic acids can then be loaded into agarose gel and visualised via electrophoresis. Expected molecular weight of the microbe helps to identify presence within the specimen.

58
Q

what are the symptoms of sepsis and how is it diagnosed?

A

sweats, disorientation, shivering, high HR, extreme pain, SOB

Diagnosing:
- history check related to symptoms and risk factors
-tests e.g. chest x-ray, CT scan, urine sample, sputum, faeces sample, bloods
- full examination: capillary refill time, skin, dehydration.
-observations: temp (feverlike), HR, RR > 30, BP

59
Q

what are the symptoms of meningitis and how is it diagnosed?

A

symptoms: fever, nausea, muscle pain, lethargy, chill, sore throat, stiff neck, unusual skin colour, non -blanching rash.

Diagnosing:
-History of patient symptoms, risk factors, rule out differential diagnosis
-physical examination - temp, HR, BP, conscious level, photosensitivity, non-blanching rash.
-diagnostic tests e.g. LP, CT scan of head, Blood tests

60
Q

What is the most appropriate antimicrobial regimens to treat sepsis?

A

Unknown source + renal function >20mls/min:

amoxicillin (IV) 1g TDS + gentamycin 5mg/kg
pen allergy: Levofloxacin(IV) 500mg BD + gentamycin (IV) 5mg/kg

Unknown source + renal function <20mls/min:
Tazosin (IV) 4.5g BD + clarithromycin (IV) 500mg BD

If chest source:
<48h treat like severe CAP
>48h treat like HAP

61
Q

What is the most appropriate antimicrobial regimens to treat meningitis?

A

Non pen allergy:
Ceftriaxone (IV) 2g OD
Pen allergy:
Chloramphenicol (IV) 25m/kg every 6 hours

If pen resistance suspected add:
Vancomycin (IV) 15-20mg/kg
or
Rifampicin (PO) 600mg BD

If viral encephalitis suspected add:
Acyclovir (IV) 10mg/kg TDS

62
Q

bacteria groups likely to be associated with different infection sites

A

Brain -bacterial meningitis
Lungs - pneumonia
reproductive system - STDs e.g. chlamydia, gonorrhea, syphilis

63
Q

recommend simple, effective and economical approach to minor illness

A
64
Q

what are common antibiotics used for minor illness

A

acute sore throat - if not resolved within a week - non pen allergy: Phenooxymethlypenicillin 500mg QDS
pen allergy: Clarithromycin 500mg BD

acute otitis externa - acetic acid 2% 1 spray TDS for 7 days